Fig. 1From: Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cellsCharacteristics of vorinostat-NPs. a XRD chromatogram; b average particle size; c TEM images; d drug-release kinetics. Empty-NPs were prepared similar to vorinostat-incorporated nanoparticles (vorinostat-NPs) in the absence of vorinostatBack to article page